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The subject of my dissertation is fraud in clinical trials in terms of ethics and law. The aim of my
research was to analyze the frequency of fraud in clinical trials of a given sample of data collected,
identify the main fraudsters and to analyze the causes that led participants in clinical trials to commit
fraud. 
In the theoretical part of my dissertation I defined the concepts of clinical trials, deception, ethical issues
and the relevant legal framework. 
The practical part contains the results of the data analysis of the incidence and causes of fraud, the main
actors of fraud and conception of recommendations, which appears to be essential for the prevention of
fraud in clinical trials. 
The data analysis and participant observation show that during 107 GCP (Good Glinical Practice) audits
conducted during the period of 2008–2013 
in 22 countries, 14 revelations of fraud in clinical trials were identified, which represents 13.1 %. Most
often fraud was committed by investigators, a total of 47.6 % of all observed groups of cheating clinical
trial participants. The main causes that led investigators to commit fraud represent a lack of eligible
patients, financial gain and personality traits. 
Based on the results obtained during my research I highlighted in the practical part of my dissertation the
ethical issues of deception and legal context. Finally, I draw attention to new ways to detect, prevent or
at least minimize fraudulent practice.
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